Efg Asset Management (North America) Corp. Arrowhead Pharmaceuticals, Inc. Transaction History
Efg Asset Management (North America) Corp.
- $585 Million
- Q3 2024
A detailed history of Efg Asset Management (North America) Corp. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Efg Asset Management (North America) Corp. holds 55,857 shares of ARWR stock, worth $1.04 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
55,857
Previous 51,828
7.77%
Holding current value
$1.04 Million
Previous $1.35 Million
19.75%
% of portfolio
0.18%
Previous 0.24%
Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
295Shares Held
91.1MCall Options Held
155KPut Options Held
426K-
Black Rock Inc. New York, NY15.7MShares$291 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$227 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.89MShares$165 Million2.59% of portfolio
-
State Street Corp Boston, MA6.35MShares$118 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.89MShares$90.6 Million1.49% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.96B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...